Loftware Blog / Pharmaceuticals

by Maureen Perroni, on March 24, 2017

Given the great risk if anything goes wrong, every element of the pharmaceutical supply chain must be held to extremely high standards. If your company is affected by the Food and Drug …

Read Story
Topics:PharmaceuticalsSupply ChainRegulatory

by Laura Johnson, on March 9, 2017

While attending the recent Pharma Packaging and Labeling event in Philadelphia, a few startling statistics that we’ve heard before resurfaced: 50%: pharmaceutical recalls due to packaging and labeling errors 60%: …

Read Story
Topics:PharmaceuticalsRegulatory

by Laura Johnson, on February 13, 2017

With the next deadline of the FDA’s Drug Supply Chain Security Act (DSCSA) less than a year away, you would expect most pharmaceutical companies to be on target for compliance …

Read Story
Topics:PharmaceuticalsRegulatorySAP Labeling

by Craig Hodgson, on October 20, 2016

The Drug Supply Chain Security Act (DSCSA) aims to protect U.S. consumers from counterfeit or contaminated pharmaceutical drugs. First signed into law by President Obama in 2013, the DSCSA includes a …

Read Story
Topics:PharmaceuticalsRegulatory

by Laura Johnson, on September 8, 2016

This past week, the FDA announced that as part of its Opiods Action Plan it is "requiring class-wide changes to drug labeling." The changes are being enacted to help inform health care providers and …

Read Story
Topics:Pharmaceuticals

by Shahroze Husain, on August 5, 2016

(VDC Research guest blog post for Loftware) US pharmaceutical companies today face a number of challenges emerging in the supply chain that are driving greater adoption of track-and-trace systems including …

Read Story
Topics:PharmaceuticalsRegulatory

by Maureen Perroni, on July 28, 2016

In many parts of the world, some patients are discovering that the lifesaving and life-sustaining medicines they rely on may not be what they seem. Recently, for example, Indonesian police discovered a …

Read Story
Topics:PharmaceuticalsCounterfeiting

by Maureen Perroni, on June 24, 2016

The FDA is expected to issue a final rule clearing up regulations of 3PLs under the DSCSA. When the Drug Supply Chain Security Act was signed into law in 2013, …

Read Story
Topics:PharmaceuticalsRegulatory

by Maureen Perroni, on April 29, 2016

Look no further - Loftware offers a comprehensive enterprise solution that meets the needs of medical device and pharmaceutical manufacturers. Loftware recently announced that they have partnered with USDM Life Sciences, …

Read Story
Topics:PharmaceuticalsMedical DevicesLabeling

by Laura Johnson, on April 6, 2016

The market for counterfeit drugs endangers consumers and costs the pharmaceutical industry billions of dollars in lost revenue each year. This market is growing. Decentralized pharmaceutical manufacturing and increasing global …

Read Story
Topics:PharmaceuticalsLabeling

by Maureen Perroni, on April 1, 2016

As it is implemented over the next decade, the Drug Supply Chain Security Act (DSCSA) will, piece-by-piece, create a track-and-trace system for pharmaceutical drugs distributed in the United States. As …

Read Story
Topics:Pharmaceuticals

by Laura Johnson, on March 30, 2016

Next year, pharmaceutical distributors will be required to comply with new track-and-trace requirements. Under the DSCSA, they'll have to report the chain of custody of each individual drug. The rules …

Read Story
Topics:PharmaceuticalsRegulatoryLabeling

by Laura Johnson, on March 24, 2016

The 4th Annual Pharmaceutical Labeling Compliance event, held last week in Boston, brought together nearly 100 professionals involved in the packaging and labeling in pharmaceuticals. Many of the sessions focused on …

Read Story
Topics:Pharmaceuticals

by Laura Johnson, on March 23, 2016

Pharmaceutical counterfeiting costs the industry billions of dollars per year, and threatens the health of millions of consumers. Cracking down on this practice is of paramount importance for manufacturers. Criminals …

Read Story
Topics:PharmaceuticalsLabeling

by Laura Johnson, on March 16, 2016

Beginning on March 1, a delayed provision of the Drug Supply Chain Security Act will finally go into effect. Pharmaceutical dispensers will be required to conduct lot-level product tracing, which …

Read Story
Topics:PharmaceuticalsLabeling